Key result
Review summarizes the differential role, regulation, and responsiveness of cardiac beta-adrenergic receptors in CHF.
This review summarizes the role, regulation, and responsiveness of beta-1 and beta-2 adrenergic receptors in congestive heart failure.
Answers are grounded in this paper and cite their sources.
Highlights receptor-specific beta-blockade potential in HF; leaves open optimal targeting in current regimens.
In recent years substantial information has become available on the function and regulation of beta-adrenergic receptors in experimental model systems and in the human heart. Beta-Adrenergic receptors mediate the positive inotropic and chronotropic effects of the sympathetic neurotransmitter norepinephrine in the heart. They can be altered in various disease states including congestive heart failure. In order to enhance understanding of beta-adrenergic receptor regulation in heart failure, we here review the present knowledge and the open question in three areas: (1) the differential role of beta 1- and beta 2-adrenergic receptors: (2) regulation of the number of cardiac beta-adrenergic receptors by drugs and disease states: and (3) regulation of the responsiveness of cardiac beta-adrenergic receptors.
No takes yet. Share an insight, caveat, or question.
Maisel et al. (2008) conducted a review in Congestive Heart Failure. Beta-adrenergic receptors was evaluated. This review summarizes the differential role, regulation of number, and responsiveness of cardiac beta-adrenergic receptors in congestive heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: